Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
97.6 GBX | +1.67% | -49.95% | -68.00% |
Jun. 06 | Transcript : Faron Pharmaceuticals Oy - Shareholder/Analyst Call | |
Jun. 04 | Faron Pharmaceuticals to Launch EUR31 Million Share Offering | MT |
Sales 2024 * | 14.4M 15.49M | Sales 2025 * | 39.09M 42.05M | Capitalization | 81.37M 87.53M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.45M | Net income 2025 * | -4M -4.3M | EV / Sales 2024 * | 7.78 x |
Net Debt 2024 * | 30.6M 32.91M | Net cash position 2025 * | 42.27M 45.46M | EV / Sales 2025 * | 1 x |
P/E ratio 2024 * |
-3.68
x | P/E ratio 2025 * |
-7.29
x | Employees | 34 |
Yield 2024 * |
1.33% | Yield 2025 * |
-
| Free-Float | 42.58% |
Latest transcript on Faron Pharmaceuticals Oy
1 day | +1.56% | ||
1 week | -50.00% | ||
Current month | -47.30% | ||
1 month | -50.63% | ||
3 months | -27.78% | ||
6 months | -72.14% | ||
Current year | -68.03% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 02-12-31 | |
Chairman | 60 | 23-03-23 | |
Founder | 46 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 97.6 | +1.67% | 43 387 |
24-06-07 | 96 | 0.00% | 191,499 |
24-06-06 | 96 | -6.80% | 241,876 |
24-06-05 | 103 | -1.90% | 138,571 |
24-06-04 | 105 | -46.15% | 620,544 |
Delayed Quote London S.E., June 10, 2024 at 04:13 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.03% | 87.95M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.54% | 22.78B | |
-10.93% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- FARN Stock